Thus, they speculated that modulating the level of SERT expression, for example, via SSRIs – which have been reported to be efficacious in treating inflammatory disorders of the skin as well as rheumatic disorders – could be effective in the treatment of CSU patients. Here, SLC6A4 is linked to rheumatic disorder.